Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Total Articles

3
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (0)

Searched Name

Zomig

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	Drugs for migraine. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2023;65:89-96. [PMID: 37266987 DOI: 10.58347/tml.2023.1678a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/03/2023] Abstract Collapse Key Words Aimovig Ajovy Botox Cafergot Cambia Cymbalta Depakote Effexor Elyxyb Emgality Ergomar Frova Gammacore Imitrex Lasmiditan Lopressor Maxalt Migranal NSAIDs Nerivio Nurtec Onzetra Xsail Qulipta Relivion Relpax Reyvow SNRIs Savi Dual Topamax Toprol Tosymra Treximet Trudhesa Ubrelvy Vyepti Zavzpret Zembrace Zomig acetaminophen adverse effects almotriptan amitriptyline antidepressants antiepileptics aspirin atenolol atogepant beta blockers bisoprolol butalbital caffeine candesartan celecoxib chlorpromazine diclofenac dihydroergotamine dosage droperidol drug interactions duloxetine efficacy eletriptan eptinezumab erenumab ergotamine fremanezumab frovatriptan galcanezumab ibuprofen lactation lasmiditan lisinopril metoclopramide metoprolol migraine nadolol naproxen naratriptan nortriptyline onabotulinumtoxinA opioids pregnancy prochlorperazine propranolol rimegepant rizatriptan safety sumatriptan timolol topiramate tricyclic antidepressants ubrogepant valproate venlafaxine verapamil zavegepant zolmitriptan Collapse MESH Headings Collapse Grants Collapse
2	Drugs for Migraine. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2020;62:153-160. [PMID: 33434187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023] Abstract Collapse Key Words Aimovig Ajovy Amerge Aventyl Botox CGRP Antibodies CGRP Receptor Antagonists Cafergot Cambia Cefaly D.H.E. 45 Depakote Effexor Elyxyb Emgality Epival Ergomar Fioricet Fiorinal Frova GammaCore Imitrex Lopressor Maxalt Migergot Migranal NSAIDs Nerivio Nurtec Onzetra Xsail Relpax Reyvow SNRIs Selective 5-HT1F Receptor Agonist Suvexx Topamax Toprol Tosymra Treximet Ubrelvy Vyepti Zembrace Zomig acetaminophen acupuncture adverse effects almotriptan amitriptyline analgesics antidepressants antiemetics antiepileptics antiseizure drugs aspirin atenolol beta blockers bisoprolol botulinum toxin butalbital caffeine candesartan celecoxib chlorpromazine diclofenac diclofenace dihydroergotamine divalproex sodium dosage droperidol drug interactions efficacy eletriptan eptinezumab erenumab ergotamine ergots fremanezumab frovatriptan galcanezumab ibuprofen lactation lasmiditan lisinopril medication overuse headache metoclopramide metoprolol migraine nadolol naproxen naratriptan nortriptyline onabotulinumtoxinA pregnancy prochlorperazine propranolol rimegepant rizatriptan sTMS safety simvastatin sumatriptan timolol topiramate tricyclic antidepressants triptans ubrogepant valproate venlafaxine verapamil vitamin D zolmitriptan Collapse MESH Headings Acupuncture Therapy Adult Analgesics/administration & dosage Analgesics/adverse effects Analgesics/therapeutic use Anti-Inflammatory Agents, Non-Steroidal/therapeutic use Antiemetics/adverse effects Antiemetics/therapeutic use Calcitonin Gene-Related Peptide Receptor Antagonists/therapeutic use Drug Interactions Ergot Alkaloids/adverse effects Ergot Alkaloids/therapeutic use Female Humans Migraine Disorders/drug therapy Migraine Disorders/prevention & control Pregnancy Serotonin 5-HT1 Receptor Antagonists/therapeutic use Tryptamines/administration & dosage Tryptamines/adverse effects Tryptamines/therapeutic use Collapse Grants Collapse
3	Lasmiditan (Reyvow) and ubrogepant (Ubrelvy) for acute treatment of migraine. THE MEDICAL LETTER ON DRUGS AND THERAPEUTICS 2020;62:35-39. [PMID: 32555120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023] Abstract Collapse Key Words Aimovig Ajovy Amerge Cafergot Cambia D.H.E. 45 Emgality Frova Imitrex Maxalt Migergot Migranal NSAIDs Onzetra Xsail Relpax Reyvow Tosymra Treximet Ubrelvy Zembrace Zomig adverse effects almotriptan diclofenac dihydroergotamine dosage drug interactions efficacy eletriptan erenumab ergotamine fremanezumab frovatriptan galcanezumab lactation lasmiditan migraine naproxen naratriptan pregnancy rizatriptan safety sumatriptan ubrogepant zolmitriptan Collapse MESH Headings Animals Benzamides/administration & dosage Benzamides/adverse effects Benzamides/pharmacology Humans Migraine Disorders/drug therapy Migraine Disorders/physiopathology Piperidines/administration & dosage Piperidines/adverse effects Piperidines/pharmacology Pyridines/administration & dosage Pyridines/adverse effects Pyridines/pharmacology Pyrroles/administration & dosage Pyrroles/adverse effects Pyrroles/pharmacology Collapse Grants Collapse